North Sea: 2,000 jobs face the axe as oil and gas firm Petrofac appoints administrators
North Sea: 2,000 jobs face the axe as oil and gas firm Petrofac appoints administrators
Homepage   /    business   /    North Sea: 2,000 jobs face the axe as oil and gas firm Petrofac appoints administrators

North Sea: 2,000 jobs face the axe as oil and gas firm Petrofac appoints administrators

Henry Saker-Clark 🕒︎ 2025-10-29

Copyright scotsman

North Sea: 2,000 jobs face the axe as oil and gas firm Petrofac appoints administrators

A total of 2,000 jobs based in the North Sea are at risk after oil and gas services firm Petrofac announced it had appointed administrators. The company employs more than 7,000 workers globally, with around 2,000 of these based at its North Sea hub in Scotland, according to reports. On Monday, the company told investors that it has applied to the High Court to appoint administrators. The move comes after the collapse of restructuring talks, which failed after the withdrawal of a key contract last week. Don’t miss the Scotsman’s daily newsletter Petrofac said it would now enter insolvency after Dutch electricity grid TenneT terminated a major contract to build windfarms. The company stressed the administration would affect the group’s main holding company. It will continue to trade and assess options for an alternative restructuring, with different merger and acquisition options also being explored with its key creditors. Advisers at corporate finance firm Teneo are expected to advise over the administration. READ MORE: Barnett Waddingham relocates to one of Glasgow’s greenest office developments “When appointed, administrators will work alongside executive management to preserve value, operational capability and ongoing delivery across the group’s operating and trading entities,” the company said. Petrofac’s UK business is based in Aberdeen and is involved in the operation of North Sea oil platforms for firms including BP and Shell. The company was worth around £6 billion at its peak in 2012 but has slumped in recent years. It was worth around £20 million when its shares were suspended in May after being severely impacted by an investigation by the Serious Fraud Office and volatile energy prices.

Guess You Like

Novartis to acquire Avidity Biosciences for about $12 billion
Novartis to acquire Avidity Biosciences for about $12 billion
Swiss drugmaker Novartis on Su...
2025-10-29